Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2023 | 37628806 | PubTator, text mining | PubMed |
| The Spectrum of the Heterozygous Effect in Biallelic Mendelian Diseases-The Symptomatic Heterozygote Issue. | Genes (Basel) | 2023 | 37628614 | PubTator, text mining | PubMed |
| Human Exome Sequencing and Prospects for Predictive Medicine: Analysis of International Data and Own Experience. | J Pers Med | 2023 | 37623486 | PubTator, text mining | PubMed |
| From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies. | Europace | 2023 | 37622577 | PubTator, text mining | PubMed |
| Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results. | Public Health Genomics | 2023 | 37607497 | PubTator, text mining | PubMed |
| Cardiac muscle physiology. | BJA Educ | 2023 | 37600215 | PubTator, text mining | PubMed |
| Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy. | Front Cardiovasc Med | 2023 | 37600050 | PubTator, text mining | PubMed |
| Cardiac Genetic Investigation of Sudden Infant and Early Childhood Death: A Study From Victims to Families. | J Am Heart Assoc | 2023 | 37589201 | PubTator, text mining | PubMed |
| Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow. | Front Cardiovasc Med | 2023 | 37583586 | PubTator, text mining | PubMed |
| Value of genotyping and scar-phenotyping for VT ablation procedures in patients with nonischemic left ventricular cardiomyopathies. | J Cardiovasc Electrophysiol | 2023 | 37579221 | PubTator, text mining | PubMed |
| Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics: a report on five patients. | Front Cardiovasc Med | 2023 | 37576110 | PubTator, text mining | PubMed |
| Novel Mutation Glu98Lys in Cardiac Tropomyosin Alters Its Structure and Impairs Myocardial Relaxation. | Int J Mol Sci | 2023 | 37569730 | PubTator, text mining | PubMed |
| Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C. | Int J Mol Sci | 2023 | 37569724 | PubTator, text mining | PubMed |
| Metoprolol or Verapamil in the Management of Patients With Hypertrophic Cardiomyopathy: A Systematic Review. | Cureus | 2023 | 37565181 | PubTator, text mining | PubMed |
| Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation. | Eur Heart J Cardiovasc Imaging | 2023 | 37562008 | PubTator, text mining | PubMed |
| Gene-echocardiography: refining genotype-phenotype correlations in hypertrophic cardiomyopathy. | Eur Heart J Cardiovasc Imaging | 2023 | 37561025 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease. | Cardiol Res | 2023 | 37559708 | PubTator, text mining | PubMed |
| Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy. | Eur Heart J Cardiovasc Imaging | 2023 | 37523765 | PubTator, text mining | PubMed |
| In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. | Hum Gene (Amst) | 2023 | 37521006 | PubTator, text mining | PubMed |
| The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy. | Medicina (Kaunas) | 2023 | 37512108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=22